Clinical Trial

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Name: SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) — clinical trial record (NCT06125327)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

Evaluating Sufenidone (SC1011) in IPF patients for efficacy and safety. Includes screening, treatment, and follow-up, with FVC decline and health checks.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-11-04.

Trial Details

NCT Number	NCT06125327
Lead Sponsor	Guangzhou JOYO Pharma Co., Ltd
Conditions	Idiopathic Pulmonary Fibrosis
Enrollment	210 participants
Start Date	2023-06-06
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-19